Monocentric study of IL-5 monoclonal antibody induction therapy for eosinophilic granulomatosis with polyangiitis

CONCLUSION: In this retrospective study, induction therapy with a 12-month 100 mg MEP quadri-weekly subcutaneous injection regimen demonstrates the efficacy and safety for active and relapsing EGPA patients.PMID:38199911 | DOI:10.1016/j.jfma.2024.01.007

Source: J Formos Med Assoc - January 10, 2024 Category: General Medicine Authors: Chrong-Reen Wang Hung-Wen Tsai Chi-Chang Shieh Source Type: research